• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

I型子宫内膜癌中雌激素受体与程序性死亡配体-1的相关性

Correlation between estrogen receptor and programmed death ligand-1 in type I endometrial cancer.

作者信息

Waluyo Setyo Teguh, Tjokroprawiro Brahmana Askandar, Rahaju Anny Setijo

机构信息

Subspecialist Education Program, Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Dr. Soetomo General Academic Hospital, Medical Faculty -Universitas Airlangga, Surabaya, Indonesia.

Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Faculty of Medicine, Universitas Airlangga/Dr.Soetomo General Academic Hospital, Surabaya, Indonesia.

出版信息

Eur J Obstet Gynecol Reprod Biol X. 2024 Feb 20;21:100293. doi: 10.1016/j.eurox.2024.100293. eCollection 2024 Mar.

DOI:10.1016/j.eurox.2024.100293
PMID:38433993
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10907181/
Abstract

OBJECTIVE

To determine the effect of estrogen receptor (ER) on programmed death-ligand 1 (PD-L1) expression in type I endometrial cancer (EC).

MATERIAL AND METHODS

This retrospective study included 85 patients with type I EC who underwent surgery at Dr. Soetomo Hospital between 2018 and 2022. A random sampling technique was employed. Immunohistochemistry (IHC) with ER and PD-L1 antibodies was performed on all samples. In this study, ER expression served as the independent variable, while PD-L1 expression was considered the dependent variable. Data analysis was performed using Spearman's rank correlation coefficient test.

RESULTS

Out of the 85 patients with type I EC, 58 (68.2%) exhibited positive and 27 (31.8%) exhibited negative ER expression. Meanwhile positive PD-L1 expression was seen in 67 (78.8%) and 18 (21.2%) exhibited negative PD-L1 expression. The study revealed a strong negative correlation between ER and PD-L1 expression in EC (rho value = -0.886, p-value = 0.0001).

CONCLUSION

ER downregulates PD-L1 in type I EC. The findings of this study can be used as reference data and as the basis for further research, especially investigations of the prognostic and immunotherapeutic value of ER and PD-L1 expression in type I EC.

摘要

目的

确定雌激素受体(ER)对I型子宫内膜癌(EC)中程序性死亡配体1(PD-L1)表达的影响。

材料与方法

这项回顾性研究纳入了2018年至2022年间在苏托莫博士医院接受手术的85例I型EC患者。采用随机抽样技术。对所有样本进行ER和PD-L1抗体的免疫组织化学(IHC)检测。在本研究中,ER表达作为自变量,而PD-L1表达被视为因变量。使用Spearman等级相关系数检验进行数据分析。

结果

在85例I型EC患者中,58例(68.2%)ER表达阳性,27例(31.8%)ER表达阴性。同时,67例(78.8%)PD-L1表达阳性,18例(21.2%)PD-L1表达阴性。研究显示EC中ER与PD-L1表达之间存在强负相关(rho值 = -0.886,p值 = 0.0001)。

结论

ER下调I型EC中的PD-L1。本研究结果可作为参考数据,并作为进一步研究的基础,特别是对I型EC中ER和PD-L1表达的预后和免疫治疗价值的研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91f/10907181/a1117ef07257/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91f/10907181/7c2d2de94d89/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91f/10907181/e50acc51c009/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91f/10907181/a1117ef07257/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91f/10907181/7c2d2de94d89/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91f/10907181/e50acc51c009/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a91f/10907181/a1117ef07257/gr3.jpg

相似文献

1
Correlation between estrogen receptor and programmed death ligand-1 in type I endometrial cancer.I型子宫内膜癌中雌激素受体与程序性死亡配体-1的相关性
Eur J Obstet Gynecol Reprod Biol X. 2024 Feb 20;21:100293. doi: 10.1016/j.eurox.2024.100293. eCollection 2024 Mar.
2
Estrogen receptor and programmed death ligand-1 expression in type 1 endometrial cancer and its associated clinicopathological characteristics.1 型子宫内膜癌中雌激素受体和程序性死亡配体-1 的表达及其与临床病理特征的关系。
Cancer Treat Res Commun. 2023;37:100766. doi: 10.1016/j.ctarc.2023.100766. Epub 2023 Sep 29.
3
Programmed Cell Death Ligand-1 (PDL-1) Correlates With Tumor Infiltration by Immune Cells and Represents a Promising Target for Immunotherapy in Endometrial Cancer.程序性细胞死亡配体 1(PDL-1)与免疫细胞浸润肿瘤相关,是子宫内膜癌免疫治疗的一个有前途的靶点。
Anticancer Res. 2022 Mar;42(3):1367-1376. doi: 10.21873/anticanres.15606.
4
Lymphocyte activation gene (LAG)-3 is a potential immunotherapeutic target for microsatellite stable, programmed death-ligand 1 (PD-L1)-positive endometrioid endometrial cancer.淋巴细胞激活基因 (LAG)-3 是微卫星稳定、程序性死亡配体 1 (PD-L1) 阳性的子宫内膜样子宫内膜癌的潜在免疫治疗靶点。
J Gynecol Oncol. 2023 Mar;34(2):e18. doi: 10.3802/jgo.2023.34.e18. Epub 2022 Dec 7.
5
Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer.程序性细胞死亡蛋白 1 及其配体在子宫内膜癌中的预后意义。
Gynecol Oncol. 2018 May;149(2):381-387. doi: 10.1016/j.ygyno.2018.02.013. Epub 2018 Mar 21.
6
Expression of programmed death-ligand 1, IRF1 and CD8 T lymphocyte infiltration in a primary subset of breast cancer patients in Sudan.苏丹原发性乳腺癌患者中程序性死亡配体1、IRF1的表达及CD8 T淋巴细胞浸润情况
J Taibah Univ Med Sci. 2023 Sep 7;19(1):99-105. doi: 10.1016/j.jtumed.2023.08.006. eCollection 2024 Feb.
7
Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8 T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer.雌激素受体通过抑制乳腺癌中的白细胞介素-17信号转导来下调PD-1/PD-L1的表达及CD8 T细胞浸润。
Front Oncol. 2020 Sep 25;10:582863. doi: 10.3389/fonc.2020.582863. eCollection 2020.
8
Prognostic effect of programmed cell death ligand 1/programmed cell death 1 expression in cancer stem cells of human oral squamous cell carcinoma.程序性细胞死亡配体1/程序性细胞死亡1表达在人口腔鳞状细胞癌癌干细胞中的预后作用
Oncol Lett. 2024 Jan 4;27(2):79. doi: 10.3892/ol.2024.14213. eCollection 2024 Feb.
9
Programmed death-ligand 1 gene expression is a prognostic marker in early breast cancer and provides additional prognostic value to 21-gene and 70-gene signatures in estrogen receptor-positive disease.程序性死亡配体 1 基因表达是早期乳腺癌的预后标志物,并且在雌激素受体阳性疾病中为 21 基因和 70 基因标志物提供了额外的预后价值。
Mol Oncol. 2020 May;14(5):951-963. doi: 10.1002/1878-0261.12654. Epub 2020 Mar 20.
10
Programmed death-1 (PD-1) and programmed death-ligand 1 (PD-L1) expressions in type 2 endometrial cancer.程序性死亡受体 1(PD-1)和程序性死亡配体 1(PD-L1)在 2 型子宫内膜癌中的表达。
Arch Gynecol Obstet. 2019 Aug;300(2):377-382. doi: 10.1007/s00404-019-05180-2. Epub 2019 May 10.

本文引用的文献

1
Role of sex and sex hormones in PD-L1 expression in NSCLC: clinical and therapeutic implications.性别和性激素在非小细胞肺癌中程序性死亡受体配体1(PD-L1)表达中的作用:临床及治疗意义
Front Oncol. 2023 Oct 24;13:1210297. doi: 10.3389/fonc.2023.1210297. eCollection 2023.
2
Expression of PD-1 and PD-L1 in Endometrial Cancer: Molecular and Clinical Significance.PD-1 和 PD-L1 在子宫内膜癌中的表达:分子和临床意义。
Int J Mol Sci. 2023 Oct 16;24(20):15233. doi: 10.3390/ijms242015233.
3
Efficacy and Safety of PD-1/PD-L1 Inhibitor as Single-Agent Immunotherapy in Endometrial Cancer: A Systematic Review and Meta-Analysis.
PD-1/PD-L1抑制剂作为单药免疫疗法治疗子宫内膜癌的疗效与安全性:一项系统评价和荟萃分析
Cancers (Basel). 2023 Aug 9;15(16):4032. doi: 10.3390/cancers15164032.
4
PD-L1 Expression in Endometrial Cancer and Its Association with Clinicopathological Features: A Systematic Review and Meta-Analysis.子宫内膜癌中PD-L1表达及其与临床病理特征的关联:一项系统综述和荟萃分析
Cancers (Basel). 2022 Aug 13;14(16):3911. doi: 10.3390/cancers14163911.
5
Five-Year Cancer Epidemiology at the National Referral Hospital: Hospital-Based Cancer Registry Data in Indonesia.五年国家转诊医院癌症流行病学:印度尼西亚基于医院的癌症登记数据。
JCO Glob Oncol. 2021 Feb;7:190-203. doi: 10.1200/GO.20.00155.
6
Cancer Statistics, 2021.癌症统计数据,2021.
CA Cancer J Clin. 2021 Jan;71(1):7-33. doi: 10.3322/caac.21654. Epub 2021 Jan 12.
7
Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8 T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer.雌激素受体通过抑制乳腺癌中的白细胞介素-17信号转导来下调PD-1/PD-L1的表达及CD8 T细胞浸润。
Front Oncol. 2020 Sep 25;10:582863. doi: 10.3389/fonc.2020.582863. eCollection 2020.
8
NF-κB and Its Role in Checkpoint Control.NF-κB 及其在检查点控制中的作用。
Int J Mol Sci. 2020 May 31;21(11):3949. doi: 10.3390/ijms21113949.
9
Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer.子宫内膜癌中的雌激素受体、孕激素受体和HER2受体标志物
J Cancer. 2020 Jan 16;11(7):1693-1701. doi: 10.7150/jca.41943. eCollection 2020.
10
PD-L1 and CD4 are independent prognostic factors for overall survival in endometrial carcinomas.PD-L1 和 CD4 是子宫内膜癌患者总生存的独立预后因素。
BMC Cancer. 2020 Feb 17;20(1):127. doi: 10.1186/s12885-020-6545-9.